课题基金 / 基金详情

New England Regional Center of Excellence in Biodefense and Emerging Infectious D

New England Regional Center of Excellence in Biodefense and Emerging Infectious D
新英格兰生物防御和新发传染病卓越区域中心
批准号:
7911021
负责人:
Dennis L. Kasper
金额:
$336.53万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-09-17 至 2011-08-31

项目摘要

项目成果

Dennis L. Kasper的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):新英格兰地区生物防御和新发传染病研究卓越中心(NERCE)已成为生物防御和新发传染病研究和开发的焦点,开发治疗和预防感染的新方法。NERCE一直支持其核心实验室,其核心实验室已被来自学术界、公共卫生部门以及总部设在新英格兰和全国各地的生物制药和生物技术行业的科学家利用。该中心作为基础、翻译和临床研究科学家进行研究的催化剂,从而开发出针对传染病的新产品。NERCE将继续这一使命,支持针对三个主要主题的研究--“高致病性RNA病毒”、“细菌毒素和其他致病蛋白”以及“革兰氏阴性细菌--发病机制和免疫”。该中心将继续强调“化学生物学”和高通量的实验发现方法。NERCE还将支持五个核心实验室--“微生物学和动物资源”、“生物分子生产”、“小分子筛选”、“目标识别”和“分子成像”。这些核心资源可供从事NIAID优先病原体和新发传染病病原体研究的整个新英格兰传染病社区使用。小分子筛选核心(生物防御和新发传染病研究卓越研究中心国家筛选实验室,或NSRB)支持隶属于十个区域中心中任何一个的科学家。NERCE还将继续其开发项目计划和生物防御职业发展计划,以努力发起新的研究努力,并吸引新的研究人员进入该领域。 相关性:通过新英格兰RCE支持的项目将提供针对生物防御和新出现的传染病病原体的治疗、疫苗和诊断开发所需的基本知识。这些方案还将为进入该领域并活跃在该领域的调查人员提供培训机会。 战略管理计划和行政核心:战略计划和管理(核心领导,D.Kasper)
英文摘要
DESCRIPTION (provided by applicant): The New England Regional Center of Excellence for Biodefense and Emerging Infectious Diseases Research (NERCE) has become a focal point for research and development in biodefense and emerging infectious diseases, developing novel approaches to treatment and prevention of infections. NERCE has supported and its core labs have been utilized by scientists from academia, the public health sector and the biopharmaceutical and biotechnology industries based in New England and across the country. The center functions as a catalyst for basic, translational and clinical research scientists to conduct research leading to new products directed against infectious disease. NERCE will continue this mission by supporting research addressing three primary themes - "Highly Pathogenic RNA Viruses", "Bacterial Toxins and other Pathogenic Proteins", and "Gram-Negative Bacteria - Pathogenesis and Immunity". The Center will continue its emphasis on "Chemical Biology" and high throughput approaches to experimental discovery. NERCE will also be supporting five core labs - "Microbiology and Animal Resources", "Biomolecule Production", "Small Molecule Screening", "Target Identification", and "Molecular Imaging". These core resources are available to the entire New England infectious disease community working on NIAID priority pathogens and agents of emerging infectious disease. The small molecule screening core (National Screening Laboratory for the Research Centers of Excellence in Biodefense and Emerging Infectious Diseases Research, or NSRB) supports scientists affiliated with any of the ten Regional Centers. NERCE will also continue its Developmental Projects program and Career Development in Biodefense program in an effort to initiate new research efforts and to attract new investigators to this field. RELEVANCE: The programs supported through the New England RCE will provide the basic knowledge necessary for development of therapeutics, vaccines, and diagnostics directed against biodefense and emerging infectious disease pathogens. These programs will also provide training opportunities for investigators entering and active in the field. STRATEGIC MANAGEMENT PLAN and ADMINISTRATION CORE: Strategic Plan and Management (Core Leader, D. Kasper)
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Elucidating the Structural Requirements for Next-Gen Glycoconjugate Vaccines
  • 批准号:
    10321266
  • 项目类别:
  • 资助金额:
    $60.46万
  • 财政年份:
    2020
  • 负责人:
    Dennis L. Kasper
  • 依托单位:
Elucidating the Structural Requirements for Next-Gen Glycoconjugate Vaccines
  • 批准号:
    10533764
  • 项目类别:
  • 资助金额:
    $61.31万
  • 财政年份:
    2020
  • 负责人:
    Dennis L. Kasper
  • 依托单位:
Elucidating the Structural Requirements for Next-Gen Glycoconjugate Vaccines
  • 批准号:
    10084269
  • 项目类别:
  • 资助金额:
    $60.46万
  • 财政年份:
    2020
  • 负责人:
    Dennis L. Kasper
  • 依托单位:
Innovative Platforms for Antimicrobial Therapy and Vaccine Development
  • 批准号:
    8641912
  • 项目类别:
  • 资助金额:
    $493.79万
  • 财政年份:
    2014
  • 负责人:
    Dennis L. Kasper
  • 依托单位:
海外基金